03/24/2026
🔬Clinical trial now enrolling!🔬
AVALON is testing the investigational drug VTP-1000 for celiac disease. This investigational targeted immunotherapy is designed to prevent or reduce symptoms from accidental gluten exposure by promoting tolerance to gluten.
You may be able to participate if you meet the following requirements:
- 18–70 years old
- Biopsy-confirmed celiac disease
- Have been on a gluten-free diet for 12+ months
- US resident
Additional eligibility criteria apply, and compensation may be available for your time and travel.
See if you qualify by calling 616-328-5344